These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 2897910

  • 21. Choosing an atypical antipsychotic.
    Sussman N.
    Int Clin Psychopharmacol; 2002 Aug; 17 Suppl 3():S29-33. PubMed ID: 12570069
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. New drugs for schizophrenia: an update for family physicians.
    Amadio PB, Cross LB, Amadio P.
    Am Fam Physician; 1997 Sep 15; 56(4):1149-56, 1159-60. PubMed ID: 9310066
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. An evaluation of a unique new antipsychotic agent, sulpiride: effects on serum prolactin and growth hormone levels.
    Mielke DH, Gallant DM, Kessler C.
    Am J Psychiatry; 1977 Dec 15; 134(12):1371-5. PubMed ID: 21571
    [Abstract] [Full Text] [Related]

  • 28. New generation antipsychotic drugs and compliance behaviour.
    Voruganti LP, Baker LK, Awad AG.
    Curr Opin Psychiatry; 2008 Mar 15; 21(2):133-9. PubMed ID: 18332660
    [Abstract] [Full Text] [Related]

  • 29. Atypical antipsychotic drugs as a first-line treatment of schizophrenia: a rationale and hypothesis.
    Lieberman JA.
    J Clin Psychiatry; 1996 Mar 15; 57 Suppl 11():68-71. PubMed ID: 8941173
    [Abstract] [Full Text] [Related]

  • 30. A study of serum prolactin levels in schizophrenia: comparison of males and females.
    Kuruvilla A, Peedicayil J, Srikrishna G, Kuruvilla K, Kanagasabapathy AS.
    Clin Exp Pharmacol Physiol; 1992 Sep 15; 19(9):603-6. PubMed ID: 1356671
    [Abstract] [Full Text] [Related]

  • 31. Examining the dopamine hypotheses of schizophrenia and of mania using the prolactin response to antipsychotic drugs.
    Silverstone T, Cookson J.
    Neuropharmacology; 1983 Apr 15; 22(4):539-41. PubMed ID: 6134252
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Interactions between procyclidine and neuroleptic drugs. Some pharmacological and clinical aspects.
    Bamrah JS, Kumar V, Krska J, Soni SD.
    Br J Psychiatry; 1986 Dec 15; 149():726-33. PubMed ID: 2878700
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Drug-induced growth hormone and prolactin responses in schizophrenia research.
    Lal S, Nair NP, Iskandar HI, Thavundayil JX, Etienne P, Wood PL, Guyda H.
    Prog Neuropsychopharmacol Biol Psychiatry; 1982 Dec 15; 6(4-6):631-7. PubMed ID: 6131495
    [Abstract] [Full Text] [Related]

  • 40. Neuroendocrine tests during treatment with neuroleptic drugs: I. Plasma prolactin response to chlorpromazine challenge.
    Kolakowska T, Fraser S, Franklin M, Knox J.
    Psychopharmacology (Berl); 1981 Dec 15; 72(3):283-5. PubMed ID: 6111824
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.